NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine (Q2905917): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 66.0 percent / rank | |||||||
Revision as of 14:59, 13 September 2021
Project Q2905917 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine |
Project Q2905917 in Portugal |
Statements
1,467,674.71 Euro
0 references
1 December 2016
0 references
30 June 2021
0 references
UNIVERSIDADE DO PORTO
0 references
Q2993198 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016385
0 references